Trade Summary

2 days ago, Kasinger James R., serving as GC, Secretary at Crispr Therapeutics AG (CRSP), sold 2,112 shares at $52.58 per share, for a total transaction value of $111,049.00. Following this transaction, Kasinger James R. now holds 85,115 shares of CRSP.

This sale represents a 2.00% decrease in Kasinger James R.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, February 19, 2026 and publicly disclosed via SEC Form 4 filing on Friday, February 20, 2026, 1 day after the trade was made.

Crispr Therapeutics AG operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.